|
| related topics |
| {customer, product, revenue} |
| {product, candidate, development} |
| {product, liability, claim} |
| {product, market, service} |
| {personnel, key, retain} |
| {acquisition, growth, future} |
| {property, intellectual, protect} |
| {stock, price, operating} |
| {cost, regulation, environmental} |
| {regulation, government, change} |
|
|
The loss of one or more of our major customers could significantly reduce our revenue and earnings.
We rely on third parties to market, distribute and sell the products incorporating our technologies and those third parties may not perform or agreements with those parties could be terminated.
We need to expand our licensing base to reduce our reliance upon several major customers.
Surface modification is a competitive market and carries the risk of technological obsolescence.
If we cannot adequately protect our technologies and proprietary information, we may be unable to sustain a competitive advantage.
We may face product liability claims related to participation in clinical trials or the use or misuse of our products.
Any adverse results in our Phase I trials for our I-vation intravitreal implant could harm our ability to commercialize the implant in a timely, cost-effective manner, if at all.
We have a single manufacturing facility and we may lose revenue and be unable to maintain our customer relationships if we lose our production capacity.
Our revenue will be harmed if we cannot purchase sufficient reagent components we use in our manufacture of reagents.
We are dependent upon key personnel and may not be able to attract qualified personnel in the future.
Our products are subject to continuing regulations and we may be subject to adverse consequences if we fail to comply with applicable regulations.
We use hazardous materials in some of our research, development and manufacturing processes.
Our stock price has been volatile and may continue to be volatile.
Failure to identify strategic investment and acquisition opportunities and integrate acquired businesses into our operations successfully may limit our growth.
Full 10-K form ▸
|
|
| related documents |
| 891288--3/29/2007--QUESTCOR_PHARMACEUTICALS_INC |
| 811641--3/23/2006--IMMUCELL_CORP_/DE/ |
| 46080--2/27/2008--HASBRO_INC |
| 56701--8/20/2007--KOSS_CORP |
| 355999--2/27/2009--UNITED_STATIONERS_INC |
| 355999--2/29/2008--UNITED_STATIONERS_INC |
| 842162--3/9/2006--LEAR_CORP |
| 862861--3/28/2008--APPLIANCE_RECYCLING_CENTERS_OF_AMERICA_INC_/MN |
| 1004608--3/30/2007--PINNACLE_DATA_SYSTEMS_INC |
| 46080--2/25/2009--HASBRO_INC |
| 93631--10/24/2008--FREDERICK'S_OF_HOLLYWOOD_GROUP_INC_/NY/ |
| 877212--2/28/2006--ZEBRA_TECHNOLOGIES_CORP/DE |
| 355999--3/6/2006--UNITED_STATIONERS_INC |
| 355999--3/1/2007--UNITED_STATIONERS_INC |
| 1104252--3/12/2007--DDI_CORP |
| 1001902--2/26/2010--INTEVAC_INC |
| 1077688--2/28/2007--HOOKER_FURNITURE_CORP |
| 862861--3/20/2009--APPLIANCE_RECYCLING_CENTERS_OF_AMERICA_INC_/MN |
| 1069353--11/21/2007--CONEXANT_SYSTEMS_INC |
| 885245--4/16/2008--BUCKLE_INC |
| 723889--3/30/2006--MFIC_CORP |
| 887227--6/13/2007--CHOLESTECH_CORPORATION |
| 891288--3/30/2006--QUESTCOR_PHARMACEUTICALS_INC |
| 822663--3/16/2007--INTER_PARFUMS_INC |
| 897429--3/28/2008--CHICOS_FAS_INC |
| 1177845--6/5/2008--XPLORE_TECHNOLOGIES_CORP |
| 1003950--3/17/2008--PERFORMANCE_TECHNOLOGIES_INC_\DE\ |
| 856250--9/13/2006--CRAFTMADE_INTERNATIONAL_INC |
| 780571--2/24/2006--ITRON_INC_/WA/ |
| 851205--2/14/2008--COGNEX_CORP |
|